Horizon Therapeutics plc to Present at the Cowen and Company 42nd Annual Health Care Conference Feb 21, 2022 04:05PM
Horizon Therapeutics plc to Present at the Cowen and Company 41st Annual Health Care Conference Feb 26, 2021 04:05PM
Horizon Therapeutics plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares Aug 11, 2020 05:00PM
Horizon Therapeutics (HZNP) Prices 11.8M Share Offering at $71 Aug 7, 2020 06:35AM
Horizon Therapeutics plc Announces Pricing of Public Offering of Ordinary Shares Aug 6, 2020 11:20PM


Aug 5, 2020 04:13PM Horizon Therapeutics (HZNP) Announces Proposed $700M Public Offering of Ordinary Shares
Aug 5, 2020 04:01PM Horizon Therapeutics plc Announces Proposed Public Offering of Ordinary Shares
Feb 18, 2020 08:30AM Horizon Therapeutics plc to Present at the Cowen and Company 40th Annual Health Care Conference
Mar 11, 2019 04:30PM Horizon Pharma plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 6, 2019 10:00PM Horizon Pharma plc Announces Pricing of Public Offering of Ordinary Shares
Mar 4, 2019 04:10PM Horizon Pharma plc Announces Proposed Public Offering of Ordinary Shares
Feb 25, 2019 08:00AM Horizon Pharma plc to Participate in Cowen and Company 39th Annual Health Care Conference
Feb 26, 2018 07:00AM Horizon Pharma plc to Participate in the Cowen and Company 38th Annual Health Care Conference
Sep 12, 2016 07:00AM Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business
Mar 1, 2016 07:00AM Horizon Pharma plc to Participate in Cowen and Company 36th Annual Health Care Conference
Apr 21, 2015 09:48AM Horizon Pharma plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares
Apr 15, 2015 06:47PM Horizon Pharma plc Announces Pricing of Public Offering of Ordinary Shares
Apr 13, 2015 04:01PM Horizon Pharma plc Announces Proposed Public Offering of Ordinary Shares
Mar 30, 2015 06:00AM Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash